Granulocyte colony stimulating factor therapy of experimental cryptococcal meningitis

Journal of Medical and Veterinary Mycology

Volumn 35, Issue 4, 1997, Pages 243-247

  Graybill, J R ^a,b   Bocanegra, R ^b   Lambros, C ^c   Luther, M F ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Cryptococcal meningitis; GCSF

Indexed keywords

FLUCONAZOLE; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DOSE TIME EFFECT RELATION; DRUG EFFICACY; FUNGAL MENINGITIS; IMMUNOTHERAPY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION;

ANIMALIA; FILOBASIDIELLA NEOFORMANS; MURINAE;

EID: 80051525056     PISSN: 02681218     EISSN: None     Source Type: Journal    
DOI: 10.1080/02681219780001221     Document Type: Article

References (17)

1. Powderly WG. Cryptococcal meningitis and AIDS. Clin Infect Dis 1993; 17: 837-42.
2. Saag MS, Powderly WG. Cloud GA, et al. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. N Engl J Med 1992; 326: 83-9.
3. Kerkering TM, Duma RJ, Shadomy S. The evolution of pulmonary cryptococcosis: clinical implication from a study of 41 patients with and without compromising host factors. Ann Intern Med 1981; 94: 611-16.
4. Bennett JE, Dismukes WE, Duma RJ, et al. A comparison of amphotericin B alone and combined with flucytosine in the treatment of cryptococcal meningitis. N Engl J Med 1979; 301: 126-31.
5. Graybill JR, Mitchell L, Drutz DJ. Host defense in cryptococcosis. III Protection of nude mice by thymus transplantation. J Infect Dis 1979; 140: 546-52.
6. Kozel TR, McGraw TG. Opsonization of Cryptococcuss neoformans by human immunoglobulin G: role of immunoglobulin G in phagocytosis by macrophages. Infect Immun 1979; 25: 255-61.
7. Graybill JR, Hague M, Drutz DJ. Passive immunization in murine cryptococcosis. Sabouraudia 1981; 19: 237-44.
8. Dromer F, Charriere J, Contrepois A, Carbon C, Yeni P. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect Immun 1987; 55: 749-52.
9. Mukherjee J, Zuckier LS, Scharff MD, Casadevall A. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glururonylxylomannan alone and in combination with amphotericin B. Antimicrob Agents Chemother 1994; 38: 580-7.
10. Rhodes JC, Wicker LS, Urba WJ. Genetic control of susceptibility to Cryptococcus neoformans in mice. Infect Immun 1980; 29: 494-9.
11. Graybill JR, Ahrens J. Immunization and complement interaction in host defense against murine cryptococcosis. J Reticuloendothel Soc 1981; 30: 347-57.
12. Williamson PR, Bennett JE, Robbins J, Schneerson R. Vaccination for prevention of cryptococcosis. In: Program and Abstracts of the Second International Conference on Cryptococcus and Cryptoccosis, Milan, Italy, 19-23 September, 1993: L22.
13. Zebedee SL, Koduri RK, Mukherjee J, et al. Mouse-human immunoglopbulin G1 chimeric antibodies with activities against Cryptococcus neoformans. Antimicrob Agents Chemother 1994; 38: 1507-14.
14. Roilides E, Walsh TJ, Pizzo PA, Rubin M. Granulocyte colony-stimulating factor enhances the phagocytic and bactericidal activity of normal and defective human neutrophils. J Infect Dis 1991; 163: 579-83.
15. Uchida K, Yamamoto Y, Klein TW, Friedman H, Yamaguchi H. Grnulocyte-colony stimulating factor facilitates the restoration of resistance to opportunistic fungi in leukopenic mice. J Med Vet Mycol 1992; 30: 293-300.
16. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing for yeasts: proposed standard M27-T. Villanova, PA: National Committee for Clinical Laboratory Standards, 1996.
17. Graybill JR, Craven PC, Mitchell L, Drutz DJ. Interaction of chemotherapy and immune defenses in experimental murine cryptococcosis. Antimicrob Agents Chemother 1978: 14: 659-67.